A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancer

Abstract excerpt

Standard treatment for metastatic prostate cancer (CaP) prevents ligand-activation of androgen receptor (AR). Despite initial remission, CaP progresses while relying on AR. AR transcriptional output controls CaP behavior and is an alternative therapeutic target, but its molecular regulation is poorly understood. Here, we show that action of activated AR partitions into fractions that are controlled preferentially...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Mass Spectrometry Techniques and Applications
• Share to Prostate Cancer Treatment and Research
• Share to Ubiquitin and proteasome pathways